Technician II, Long Oligo - Mon - Fri, 11:00am - 7:30pm
Danaher Corporation
Summary
The Technician II (Formulation) is responsible for formulating custom oligonucleotides according to the customer's specifications. This generally includes quantification, final packaging, and QC sampling of the products being made.
Job description
This position reports to the Supervisor, Long Oligo, and is part of the Long Oligo Value Stream located in Coralville, IA, and will be an on-site role. Shift: Monday - Friday, 11:00am - 7:30pm
In this role, you will have the opportunity to:
- Uses automated and manual lab equipment accurately; including limited maintenance and troubleshooting activities
- Translates order requirements into a process to formulate oligos to the customer's specifications
- Assesses QC data accurately and makes pass/fail decisions for oligos
The essential requirements of the job include:
- High School diploma, GED, or equivalent
- Some laboratory experience
- Proficiency in a variety of PC software programs with strong working knowledge of Microsoft Office
It would be a plus if you also possess previous experience in:
- An associate degree or higher
- 12 months of lab experience; Life Science work experience preferred
- Extensive computer skills which include knowledge of the Internet, Microsoft Excel and Microsoft Word
Requirements
- High School diploma, GED, or equivalent
- Some laboratory experience
- Proficiency in a variety of PC software programs with strong working knowledge of Microsoft Office
- Associate degree or higher (preferred)
- 12 months of lab experience (preferred)
- Life Science work experience (preferred)
- Extensive computer skills including Internet, Microsoft Excel and Microsoft Word (preferred)
Benefits
- Paid Time Off
- Medical Insurance
- Dental Insurance
- Vision Insurance
- 401(k)
- Bonus/Incentive Pay
Company overview
Danaher Corporation is a leading global science and technology innovator headquartered in Washington, D.C., specializing in biotechnology, life sciences, and diagnostics. Founded in 1984 by brothers Steven and Mitchell Rales, the company has evolved from its origins as a manufacturing conglomerate into a premier healthcare technology organization with approximately 63,000 employees worldwide. Danaher operates through three core divisions: biotechnology (28% of revenues), which develops products for therapeutic development; life sciences (31% of revenues), focused on disease identification, new therapies, and drug testing/manufacturing; and diagnostics (41% of revenues), providing instruments, consumables, and software for disease diagnosis. The company's portfolio includes renowned brands such as Beckman Coulter, Cytiva, Pall Corporation, Cepheid, Leica Microsystems, and Abcam, serving pharmaceutical companies, biotechnology firms, healthcare providers, and research institutions globally. Danaher is distinguished by its Danaher Business System (DBS), a continuous improvement methodology that drives innovation and operational excellence. With 2024 revenues of $23.9 billion, the company ranks 180th on the Fortune 500 and plays a critical role in advancing scientific research, improving diagnostic capabilities, and accelerating the development of life-saving therapies.